Abstract
Translation in eukaryotes is highly regulated during initiation, a process impacted by numerous readouts of a cell's state. There are many cases in which cellular messenger RNAs likely do not follow the canonical ‘scanning’ mechanism of translation initiation, but the molecular mechanisms underlying these pathways are still being uncovered. Some RNA viruses such as the hepatitis C virus use highly structured RNA elements termed internal ribosome entry sites (IRESs) that commandeer eukaryotic translation initiation, by using specific interactions with the general eukaryotic translation initiation factor eIF3. Here, I present evidence that, in addition to its general role in translation, eIF3 in humans and likely in all multicellular eukaryotes also acts as a translational activator or repressor by binding RNA structures in the 5′-untranslated regions of specific mRNAs, analogous to the role of the mediator complex in transcription. Furthermore, eIF3 in multicellular eukaryotes also harbours a 5′ 7-methylguanosine cap-binding subunit—eIF3d—which replaces the general cap-binding initiation factor eIF4E in the translation of select mRNAs. Based on results from cell biological, biochemical and structural studies of eIF3, it is likely that human translation initiation proceeds through dozens of different molecular pathways, the vast majority of which remain to be explored.
This article is part of the themed issue ‘Perspectives on the ribosome’.
Keywords: translation initiation, eIF3, mediator, IRES, eIF4E, eIF3d
1. Introduction
For most genes, the connection between genotype and phenotype requires protein synthesis, translation of the genetic code in messenger RNA (mRNA) into functional proteins. The fundamental mechanisms of how proteins are synthesized on the ribosome are now the subject of sophisticated biochemical and biophysical experiments that build on the insights from the first atomic-resolution structural models of the ribosomal subunits and intact ribosome, including many publications from Venki Ramakrishnan's laboratory [1]. Structural insights into translation are accelerating with the advent of new technologies for cryo-electron microscopy (cryo-EM) [2,3]. However, the myriad ways that cells regulate how and when mRNAs are translated remain to be understood in mechanistic terms.
In eukaryotes, translation initiation serves as a key ‘gatekeeper’ to protein production levels. A canonical model for translation initiation has emerged that requires over a dozen translation initiation factors or eIFs [4]. Cellular mRNAs are capped with a 7-methylguanosine (m7G) structure at the 5′ end recognized by translation initiation factor eIF4E. Once assembled with eIF4E in the context of a larger eIF4F complex, mRNAs are recruited to the small (40S) subunit of the ribosome that harbours additional initiation factors in a 43S complex. Finally, helicases in eIF4F help the 48S pre-initiation complex scan the mRNA from the 5′ end to the appropriate start codon, usually but not always the first encountered [5]. The two initiation factors eIF4E and eIF2 are known to serve as major focal points of translation regulation. Multiple pathways that sense cellular metabolism and stress converge on eIF4E to determine the level of translation from cellular mRNAs, and include the mechanistic target of rapamycin complex 1 and MAPK-interacting kinases Mnk1 and Mnk2 [6,7]. In parallel and not entirely independently, the nutritional state of the cell and stress control the levels of active eIF2, which delivers initiator tRNA to translation pre-initiation complexes [5,6,8]. These pathways, when perturbed, can contribute to human diseases including cancer [7,9,10].
Although eIF4E acts at the start of the scanning mechanism of translation initiation, many variations have been identified that tune the levels of protein synthesis for select mRNAs, including upstream open reading frames (uORFs) that modulate the expression of a downstream ORF [11]. In the case of yeast GCN4 and human ATF4, uORFs connect levels of translation of these critical transcription factors directly to the nutritional state of the cell [6,11]. Another prominent example common among positive-strand RNA viruses is the use of structured RNA elements in the 5′ untranslated regions (5′UTRs) preceding virally encoded ORFs. These structured regions—termed internal ribosome entry sites or IRESs—recruit the translational machinery directly to the start codon [4]. Viral IRES elements are thought to help viruses circumvent immune surveillance mechanisms that repress general translation, mediated by reducing active levels of eIF2, the initiation factor that loads initiator tRNAMeti at the start codon in the 48S complex [12–14]. Other sequence- and structure-specific mechanisms for regulating translational efficiency of classes of mRNAs are beginning to emerge, including, for example, 5′-terminal oligopyrimidine sequences in mRNAs [15], TISU elements [16], structured RNA elements in histone mRNAs [17] and in the 5′UTRs of homoeobox (Hox) genes [18], RNA elements that lead to ribosome shunting [16] and other translational enhancers [19]. Finally, gathering evidence indicates that mRNAs can be post-transcriptionally modified with pseudouridine, N6-methyladenosine and N1-methyladenosine [20]. How these regulate translation initiation remains unclear. However, evidence suggests that N6-methyladenosine can stimulate translation initiation in conditions in which eIF4E is limiting [20].
Here I describe how recent advances in understanding the structure and function of translation initiation factor eIF3 help illuminate the wide variety of initiation mechanisms that are likely to exist in eukaryotes. This review focuses primarily on mammalian eIF3, with reference to other organisms such as the yeast Saccharomyces cerevisiae to highlight universal features of eIF3 structure and function. In most multicellular eukaryotes, eIF3 is composed of 13 subunits, named eIF3a–eIF3m [21–23]. Land plants, which diverged from animals about 1.6 billion years ago [24], retain a 13-subunit eIF3 complex [25], and Arabidopsis and wheat germ extracts have been used extensively to study translation initiation [25]. Filamentous fungi—less evolutionarily diverged from metazoans—also contain a 13-subunit eIF3 [23]. Although S. cerevisiae eIF3 has contributed greatly to our understanding of eIF3 function [5], it is composed of only six subunits [21]. These six subunits (eIF3a, eIF3b, eIF3c, eIF3g, eIF3i and eIF3j) are conserved with those in humans, but may have evolved distinct regulatory roles in yeast when compared with multicellular eukaryotes, for example in interactions with other initiation factors [26,27].
2. Discovery of eIF3 and its roles in general translation initiation
Mammalian eIF3, originally isolated by biochemical fractionation and functional reconstitution of translation initiation, is the largest of the translation initiation factors, with a molecular mass of approximately 800 kDa. Most of its subunits were identified by the mid-1970s. The Staehelin and Blobel laboratories were the first to note the multiple protein composition of eIF3 [28,29], and identified nine to 10 separate polypeptides [29,30]. Hershey was able to identify 11 bands in eIF3 purified from rabbit reticulocytes [31]. Its full composition, however, took many decades to decipher owing to the presence of one labile subunit—eIF3j [32]—and a second with anomalous mobility on denaturing gels—eIF3m [22,33]—that may also be labile in the eIF3 complex [34,35].
Although the composition of mammalian eIF3 took significant effort to establish, its central roles in translation initiation were identified in the 1970s using in vitro reconstitution of translation on natural mRNAs and viral genomes with biochemically fractionated factors. The Anderson laboratory initially described eIF3 (IF-M3) as required for translation of natural mRNAs but not poly-U [36]. A similar activity was described by Heywood [37], and was additionally shown to be required for ribosome recycling [38]. In parallel efforts, the Staehelin laboratory showed that eIF3 (IF-E3) is required for binding Met-tRNAMeti to the 40S subunit in the absence of mRNA [28], the first evidence for the role of eIF3 in the formation of the 43S pre-initiation complex identified by Hunt & Jackson [39] and Hirsch [40,41]. Making the first connection between eIF3 and viral translation, Strycharz et al. [42] showed that eIF3 is essential for translation of the encephalomyocarditis viral RNA.
During subsequent years, multiple groups refined the purification of most of the translation initiation factors, allowing for a much deeper analysis of initiation mechanisms [43–49]. Of particular note with respect to eIF3 function, purified eIF3 could be phosphorylated [50] or reductively methylated [44,51] in vitro and tracked through the various steps of initiation. Using radiolabelled eIF3, these groups showed eIF3 binds the 40S subunit in the absence of other translation initiation factors, stabilizes eIF2/Met-tRNAMeti/GTP binding to the 40S subunit, is required for maximal binding of natural mRNAs to the 40S subunit, inhibits 60S subunit joining and is released upon 80S initiation complex formation [44,50,51] (figure 1). Thus, even at this early stage in understanding eukaryotic translation initiation—before the role of the eIF4F complex had been established [46–49] and the remaining core initiation factor, eIF5B, had been found [53]—the central importance of eIF3 to translation initiation was apparent.
Figure 1.
Early model for the mechanism of translation initiation. The nomenclature of initiation factors changed as follows [52]: eIF-1 now eIF1, eIF-2 now eIF2, eIF-3 now eIF3, eIF-4A now eIF4A, eIF-4B now eIF4B, eIF-4C now eIF1A, eIF4-D now eIF5A, eIF-5 now eIF5. Figure from [44].
3. Early insights into eIF3 structure and binding to pre-initiation complexes
Structurally, James Lake and collaborators showed quite soon after its discovery that eIF3 associates with the platform of the 40S ribosomal subunit [54] (figure 2), but its overall architecture remained unclear. Bielka and co-workers first proposed eIF3 to be flat and triangular in shape [55,56]. The first three-dimensional reconstruction of eIF3 bound to the 40S subunit determined by Joachim Frank's laboratory, at approximately 5 nm resolution, more clearly revealed eIF3 projecting away from the platform and the interface between the two ribosomal subunits [57]. From these early structural results, it was not yet clear how eIF3 accomplished its roles in translation initiation or recycling, although Bielke's group found it to be located in close proximity to eIF2, which bound between the head and body of the 40S subunit [58]. In 2005, the Doudna and Nogales groups published the first cryo-EM reconstruction of eIF3, revealing its five-lobe architecture for the first time [59]. This reconstruction at approximately 30 Å resolution coupled with additional EM images identified the possible location of eIF4G binding to eIF3, and the position of the HCV IRES bound to eIF3 off the ribosome. Notably, the authors combined these reconstructions with modelling based on the three-dimensional reconstruction of negative-stain images of eIF3 bound to the 40S subunit [57] to provide a framework for understanding eIF3 structure and function. Although state-of-the-art at the time, the low resolution led the authors to contour the EM map to enclose a volume consistent with the molecular mass of the imaged particle, in this case approximately 800 kDa in mass. However, the choice of contour level is directly impacted by the assumption that a particle is rigid at the resolution of the reconstruction. As described in §4, eIF3 turns out to be highly flexible outside of its core, a feature of the complex not appreciated structurally for many years.
Figure 2.
Negative stain EM images of ‘native’ 40S subunits. (a) Examples of negatively stained particles. (b) Model of eIF3 bound to the 40S subunit, in three orientations. These 40S subunit preparations retained eIF3 bound to the platform region. From [54].
With the identification of the genes for nearly all of the subunits in eIF3 [60], it was possible to identify its evolutionary similarity to the COP9 signalosome—or CSN complex—and 26S proteasome regulatory lid complex [61–65]. However, advances into the mechanisms of eIF3 function during these years occurred primarily by using genetics in S. cerevisiae and biochemistry to study the conserved subunits eIF3a, b, c, g, i and j. Hinnebusch and co-workers used yeast to map interactions between eIF3 domains [66–68], and to identify a previously unknown ‘multifactor complex’ (MFC) between eIF3, eIF1, eIF2, eIF5 and initiator tRNA(Met) as a bona fide translational intermediate in the assembly of translation initiation complexes in vivo [67–69]. Several following papers identified contacts between eIF3 subunits, other translation initiation factors in the MFC, eIF4G and the 40S subunit important for translation initiation in yeast [70]. However, while many of these interactions may be conserved across eukaryotes, some aspects of translation initiation have likely diverged. In addition to the larger number of subunits in eIF3, the MFC in humans seems to involve different interactions between the eIFs than in yeast, and furthermore may participate in multiple pathways of delivering Met-tRNAi to the 40S subunit during 43S complex assembly [71].
4. Insights into mechanisms of mammalian eIF3 in translation initiation
Attempts to biochemically dissect mammalian eIF3 lagged those in yeast, owing to the difficulty in reconstituting the complex to enable mutagenesis. However, purified factors enabled a number of new insights into eIF3 function. Studies with purified translation factors helped identify the biochemical role of eIF3 in preventing 40S and 60S subunit association after recycling, an activity that required the ternary complex of eIF2/GTP/Met-tRNAi [72]. Purified translation factors also enabled the first mapping of translation factor requirements for viral IRES translation initiation, in particular how eIF3 and other factors interact with different types of IRES [73,74]. To begin dissecting mammalian eIF3, the Hershey and Sonenberg groups used baculovirus expression in insect cells to reconstitute mammalian eIF3 subassemblies comparable to the yeast eIF3 complex [75] and eIF3 with up to 11 subunits in composition [34]. Using a complex of six subunits—interestingly lacking two universally conserved in eukaryotes, eIF3g and eIF3i—the Sonenberg group could demonstrate that this minimal mammalian eIF3 (eIF3a, b, c, e, f and h) assembled translation initiation complexes in vitro [34]. Unfortunately, it has not been possible to test the function of this six-subunit complex in multicellular eukaryotes, as several of the non-essential subunits in vitro are essential in vivo [76–78].
My laboratory began working on determining the structure of human eIF3 in the late 2000s, making the choice to reconstitute human eIF3 using Escherichia coli as an expression host rather than using baculovirus expression or native purification. Although this precluded isolating eIF3 with possible post-translational modifications [33,79], it would allow us to functionally dissect eIF3 with far more precision than we could with natively purified eIF3 [80], and potentially with high enough yields for structural biology. We found that it was possible to functionally reconstitute human eIF3 in E. coli, minus two flexible regions—the C-terminus of eIF3a and N-terminus of eIF3c—and the first four amino acids of eIF3a [81]. This reconstitution revealed the eight-subunit structural core of eIF3, related in architecture to the proteasomal lid and COP9 signalosome through its PCI/MPN (proteasome, CSN, eIF3/Mpn1 Pad1-N-terminal) domain containing subunits: eIF3a, eIF3c, eIF3e, eIF3f, eIF3h, eIF3k, eIF3l and eIF3m [65]. Remarkably, the core of eIF3, about 400 kDa in mass, had the same overall shape as intact eIF3 (figure 3). Thus, from these first reconstitutions, it became abundantly clear that at least half of eIF3 was conformationally dynamic [81] and would require imaging in intact pre-initiation complexes to determine its structure to high resolution. Notably, hints of eIF3 flexibility had already been observed with respect to eIF3j, which approaches the mRNA decoding centre of the 40S subunit from the side facing the 60S subunit, in nearly the opposite direction to the known binding site of eIF3 to the 40S subunit platform [82]. Our reconstitutions of eIF3 using E. coli also revealed that eIF3 function for at least HCV IRES-mediated translation initiation would require all of the 12 stably associated subunits of eIF3, minus possibly only eIF3j; subassemblies lacking eIF3b, eIF3g and eIF3i were not functional [81].
Figure 3.
Structural core of human eIF3. Comparisons of negatively stained reconstructions of recombinant 12-subunit eIF3 (approx. 700 kDa), eight-subunit core of eIF3 (approx. 400 kDa), and the cryo-EM reconstruction of natively purified intact eIF3 (approx. 800 kDa). From [81].
Using E. coli reconstituted eIF3 also allowed us to map the position of subunits in the mammalian complex for the first time [27]. We used N-terminal MBP or GST tags and comparisons with the proteasome lid architecture [83–85] to identify the locations of each of the eight core subunits, along with the approximate positions of eIF3d and eIF3j N-termini (figure 4). We also identified binding between the eIF3 core and eIF1, interactions possibly conserved in the MFC [70,71]. Interestingly, mammalian eIF3 also interacts with eIF1A, perhaps through interactions that differ between yeast and humans. In yeast, contacts between eIF1A and yeast eIF3 occur in flexible and less-conserved N-terminal regions of eIF3c deleted in the reconstituted human eIF3 complex [26,27].
Figure 4.
Cryo-EM reconstruction of the 8-subunit core of human eIF3. The position of the eight subunits in the core of eIF3, left, were determined by N-terminal tagging and comparison with the proteasomal lid, right. From [27].
5. Towards atomic-resolution structural understanding of eIF3 function
The cryo-EM reconstruction of the human eIF3 core complex was determined at quite low resolution, of about 15–20 Å (figure 4), but did allow homology modelling of the PCI/MPN subunits and nearby alpha-helical repeat segments, by comparison with atomic-resolution structures of subunits within the proteasome lid [27,86]. Using homology models within the low-resolution cryo-EM map allowed us to use a resolution at the level of ‘blobology’ to identify two previously unrecognized RNA-binding motifs in eIF3 [87]. These two predicted RNA-binding helix–loop–helix (HLH) motifs are located at the N-terminus of eIF3a and near the N-terminus of eIF3c, just C-terminal of the less-conserved region of eIF3c beginning near amino acid 302. We could show by mutagenesis that the motif in subunit eIF3a is critical for eIF3 binding to both the HCV IRES, and to the 40S ribosomal subunit, and seems to control initial recognition of the AUG start codon. By contrast, the RNA-binding motif in eIF3c is less critical for 40S subunit and IRES binding, but influences the later step of eIF5B-mediated 60S subunit joining [87] (figure 5).
Figure 5.
Roles of helix–loop–helix RNA-binding motifs in eIF3 in HCV IRES-mediated translation. The motif in subunit eIF3a mediates start codon recognition, whereas the motif in eIF3c contributes to a later step involving eIF5B. From [27].
Given the size of the RNA-binding motifs, it was puzzling that the HLH motif in eIF3a is important both for binding to the HCV IRES and to the 40S ribosomal subunit. How could a small protein motif bind both the HCV IRES and the 40S subunit at the same time? Sterically, this seemed implausible, and we wondered if it might be involved in serial interactions during pre-initiation complex formation. Remarkably, two cryo-EM reconstructions of mammalian eIF3 bound to the 40S subunit, one in a 43S-like complex [88] and a second in complex with the HCV-like CSFV IRES and 40S subunit [89], revealed two different modes of eIF3 binding. In the 43S complex, eIF3 binds the platform of the 40S subunit, whereas the IRES displaces eIF3 from the 40S through direct IRES RNA–protein interactions (figure 6a). These results helped explain how the HLH motif in eIF3a could be responsible both for binding to the 40S subunit and HCV IRES. In a subsequent structural investigation of eIF3 bound to the 40S subunit that combined the approximately 12 Å cryo-EM reconstruction of the 43S complex [88], X-ray crystal structures of yeast eIF3 subunits and subcomplexes and cross-linking–mass spectrometry, it was possible to model the interaction between the HCV IRES and subunits eIF3a and eIF3c at the amino acid and RNA nucleotide resolution (figure 6b) [90].
Figure 6.
Different modes of eIF3 binding to pre-initiation complexes. (a) Left: a 43S pre-initiation complex. Right: eIF3 bound to a classical swine fever virus (CSFV) IRES-40S complex. Figures adapted from [88,89]. (b) Model of the CSFV IRES interactions with subunits eIF3a and eIF3c. From [90].
Structural insights into eIF3 and translation initiation are continuing at a rapid pace, using both yeast and mammalian systems for cryo-EM reconstructions [91–93]. One of the most striking findings of these cryo-EM reconstructions is the fact that eIF3 effectively wraps around the 40S subunit, reaching from under the mRNA decoding site—the binding location for eIF1A [93] (figure 7a)—to the 40S subunit platform [91–93] and then entirely around the solvent side of the 40S subunit reaching past the mRNA entry tunnel [90–93] (figure 7b). The core of mammalian eIF3 is the most distal part of the eIF3 complex from the 80S ribosomal subunit interface (figure 6a), with extensions from the core extending to contact multiple regions of the pre-initiation complex (figure 7). Furthermore, these extensions are highly dynamic even in the context of pre-initiation complexes, both in yeast and mammals [93,94]. These cryo-EM reconstructions will enable many new biochemical and genetic explorations of eIF3 function in translation in the years to come.
Figure 7.
Models of eIF3 wrapping around the entirety of the 40S ribosomal subunit. (a) Yeast 48S pre-initiation complex, viewed from the perspective of the 60S subunit interface. Adapted from [93]. (b) Model of mammalian eIF3 bound to the 40S subunit, viewed from the solvent side of the 40S subunit. Updated from [90].
6. Roles of eIF3 as the ‘mediator’ of translation initiation
The role of eIF3 in stimulating translation initiation from structured viral IRES elements [4] by binding directly to the highly structured HCV IRES and not the 40S ribosomal subunit [89] raises questions of how general this mechanism of initiation may be. To test whether eIF3 controls alternative modes of translation initiation on cellular transcripts, we used photoactivatable-ribonucleoside-enhanced cross-linking and immunoprecipitation [95] with 4-thiouridine to identify transcripts that specifically interact with eIF3 in human 293T cells. Although we were concerned that we may only purify eIF3 cross-linked near the start codon [96], surprisingly, we found highly discrete sites of cross-linking to approximately 500 cellular transcripts [97]. Of these, most sites of cross-linking occurred at the 5′UTR as would be expected for the role of eIF3 in initiation. These mRNAs fell into distinct regulatory categories related to cell proliferation, the cell cycle, apoptosis and differentiation. Remarkably, we found that eIF3 binding to secondary structural elements in the 5′UTR of select mRNAs could not only activate translation, but could also repress translation. For example, translation of JUN mRNA, encoding the immediate early response transcriptional regulator c-Jun in the AP-1 transcription factor, is activated by eIF3. By contrast, BTG1 mRNA, encoding a transcriptional regulator B-cell translocation gene 1 that promotes terminal differentiation, is repressed by eIF3. Both these activities of eIF3 depend on the 5′ 7-methylguanosine cap on the mRNA [97].
The eIF3-binding sites within the mRNAs that cross-linked to eIF3 interact with four of its subunits—eIF3a, eIF3b, eIF3d and eIF3g—in all possible combinations of 1,2, 3 and 4 of the subunits. Although it is possible that the differences in cross-linking pattern could be due in part to the distribution of uridines in the sequences (i.e. the sites of 4-thiouridine incorporation), the pattern of cross-linking suggests that there may in fact be dozens of different ways that mRNAs are recruited to the 40S subunit for translation initiation, hints of which have already been revealed in cryo-EM reconstructions of the 43S pre-initiation complex and classical swine fever virus (CSFV) IRES pre-initiation complex (figure 6) [88,89]. In support of this idea, two of the mRNAs we characterized in depth—JUN and BTG1—harbour distinct secondary structures in their 5′UTRs that either activate or repress translation, respectively [97].
7. eIF3 possesses a 5′ m7G cap-binding subunit
The 5′ cap dependence of JUN mRNA translation activation requires a mechanistic explanation. Why, when the eIF3-binding secondary structure in the JUN mRNA is mutated thereby disrupting translation of c-Jun, does the eIF4F cap-binding complex not substitute to drive translation initiation? More generally, conditions of stress or nutrient deprivation lead to eIF4E sequestration and inactivation, yet many transcripts in the cell continue to be translated well [98], including JUN [99–101]. By analysing JUN mRNA translation initiation, we discovered that the eIF4F complex is not involved in JUN translation, which instead depends on a previously unknown 5′ cap-binding activity in subunit eIF3d [102]. Using the same cross-linking approach originally pioneered by Nahum Sonenberg to identify eIF4E [46,103], we found that eIF3d binds specifically to the 5′ m7G cap. However, cap-binding by eIF3d does not seem to occur for mRNAs in general. We determined the X-ray crystal structure of the eIF3d cap-binding domain and found a striking homology to the recently identified DXO family of cap exonucleases [104]. However, eIF3d has an ‘RNA gate’ motif that blocks access to the 5′ cap-binding pocket. Only upon allosteric activation by specific RNA structures—exemplified by the eIF3-binding site in the JUN 5′UTR—does eIF3d bind the cap to promote translation [102]. Notably, the JUN mRNA also includes an RNA element near the 5′ cap that prevents eIF4F binding and activation of translation, likely to enforce the eIF3 dependence of JUN translation to specific biological contexts (figure 8). Inhibition of eIF4F activity to promote alternative translation pathways is also required for the translation of homoeobox mRNAs [18]. The cap-binding domain in eIF3d—universally conserved in multicellular eukaryotes—likely serves to drive the translation of select regulatory mRNAs, many of which may also encode RNA structures that prevent the action of eIF4F in translation initiation [102].
Figure 8.
Mechanism of 5′ m7G cap-binding by eIF3 in translation of JUN mRNA. Upon binding the specific stem–loop in the JUN 5′UTR, eIF3d binds the 5′ cap to promote translation. An RNA element near the 5′ cap prevents eIF4F activation of JUN mRNA translation. Updated from [102].
8. Conclusion
The surprising discovery that eIF3 can activate or repress translation of specific mRNAs bears a striking parallel to the role of the mediator complex in transcription [97,105]. In the future, it will be important to identify trans-acting factors that are likely required for the function of eIF3 in transcript-specific translation regulation. Further efforts to understand how eIF3 stimulates translation of mRNAs marked with N6-methyladenosine [106] will also require new mechanistic insights. Finally, all of these newly identified biological roles for eIF3 will require new structural insights into both the canonical scanning model, and into the molecular events underlying the myriad additional translational regulatory pathways that are continuing to be uncovered.
Acknowledgements
The author thanks J. Erzberger, N. Ban, Y. Hashem, J. Llácer, T. Hussain, V. Ramakrishnan and A. Lee for sharing figure panels.
Competing interests
I have no competing interests.
Funding
This work was supported by funding from the NIH, grant no. P50-GM102706.
References
- 1.Ramakrishnan V. 2014. The ribosome emerges from a black box. Cell 159, 979–984. ( 10.1016/j.cell.2014.10.052) [DOI] [PubMed] [Google Scholar]
- 2.Glaeser RM. 2016. How good can cryo-EM become? Nat. Methods 13, 28–32. ( 10.1038/nmeth.3695) [DOI] [PubMed] [Google Scholar]
- 3.Nogales E. 2016. The development of cryo-EM into a mainstream structural biology technique. Nat. Methods 13, 24–27. ( 10.1038/nmeth.3694) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jackson RJ, Hellen CUT, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113–127. ( 10.1038/nrm2838) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hinnebusch AG. 2014. The scanning mechanism of eukaryotic translation initiation. Annu. Rev. Biochem. 83, 779–812. ( 10.1146/annurev-biochem-060713-035802) [DOI] [PubMed] [Google Scholar]
- 6.Chantranupong L, Wolfson RL, Sabatini DM. 2015. Nutrient-sensing mechanisms across evolution. Cell 161, 67–83. ( 10.1016/j.cell.2015.02.041) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Siddiqui N, Sonenberg N. 2015. Signalling to eIF4E in cancer. Biochem. Soc. Trans. 43, 763–772. ( 10.1042/BST20150126) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Baird TD, Wek RC. 2012. Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv. Nutr. 3, 307–321. ( 10.3945/an.112.002113) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dibble CC, Manning BD. 2013. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat. Cell Biol. 15, 555–564. ( 10.1038/ncb2763) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Truitt ML, Ruggero D. 2016. New frontiers in translational control of the cancer genome. Nat. Rev. Cancer 16, 288–304. ( 10.1038/nrc.2016.27) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hinnebusch AG. 2005. Translational regulation of GCN4 and the general amino acid control of yeast. Annu. Rev. Microbiol. 59, 407–450. ( 10.1146/annurev.micro.59.031805.133833) [DOI] [PubMed] [Google Scholar]
- 12.Pestova TV, de Breyne S, Pisarev AV, Abaeva IS, Hellen CUT. 2008. eIF2-dependent and eIF2-independent modes of initiation on the CSFV IRES: a common role of domain II. EMBO J. 27, 1060–1072. ( 10.1038/emboj.2008.49) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dmitriev SE, Terenin IM, Andreev DE, Ivanov PA, Dunaevsky JE, Merrick WC, Shatsky IN. 2010. GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J. Biol. Chem. 285, 26 779–26 787. ( 10.1074/jbc.M110.119693) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Skabkin MA, Skabkina OV, Dhote V, Komar AA, Hellen CUT, Pestova TV. 2010. Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling. Genes Dev. 24, 1787–1801. ( 10.1101/gad.1957510) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Meyuhas O, Kahan T. 2015. The race to decipher the top secrets of TOP mRNAs. Biochim. Biophys. Acta 1849, 801–811. ( 10.1016/j.bbagrm.2014.08.015) [DOI] [PubMed] [Google Scholar]
- 16.Haimov O, Sinvani H, Dikstein R. 2015. Cap-dependent, scanning-free translation initiation mechanisms. Biochim. Biophys. Acta 1849, 1313–1318. ( 10.1016/j.bbagrm.2015.09.006) [DOI] [PubMed] [Google Scholar]
- 17.Martin F, Barends S, Jaeger S, Schaeffer L, Prongidi-Fix L, Eriani G. 2011. Cap-assisted internal initiation of translation of histone H4. Mol. Cell. 41, 197–209. ( 10.1016/j.molcel.2010.12.019) [DOI] [PubMed] [Google Scholar]
- 18.Xue S, Tian S, Fujii K, Kladwang W, Das R, Barna M. 2015. RNA regulons in Hox 5' UTRs confer ribosome specificity to gene regulation. Nature 517, 33–38. ( 10.1038/nature14010) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gilbert WV. 2010. Alternative ways to think about cellular internal ribosome entry. J. Biol. Chem. 285, 29 033–29 038. ( 10.1074/jbc.R110.150532) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gilbert WV, Bell TA, Schaening C. 2016. Messenger RNA modifications: form, distribution, and function. Science 352, 1408–1412. ( 10.1126/science.aad8711) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Browning KS, Gallie DR, Hershey JW, Hinnebusch AG, Maitra U, Merrick WC, Norbury C. 2001. Unified nomenclature for the subunits of eukaryotic initiation factor 3. Trends Biochem. Sci. 26, 284 ( 10.1016/S0968-0004(01)01825-4) [DOI] [PubMed] [Google Scholar]
- 22.Unbehaun A, Borukhov SI, Hellen CUT, Pestova TV. 2004. Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. Genes Dev. 18, 3078–3093. ( 10.1101/gad.1255704) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Smith MD, Arake-Tacca L, Nitido A, Montabana E, Park A, Cate JH. 2016. Assembly of eIF3 mediated by mutually dependent subunit insertion. Structure 24, 886–896. ( 10.1016/j.str.2016.02.024) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Meyerowitz EM. 2002. Plants compared to animals: the broadest comparative study of development. Science 295, 1482–1485. ( 10.1126/science.1066609) [DOI] [PubMed] [Google Scholar]
- 25.Browning KS, Bailey-Serres J. 2015. Mechanism of cytoplasmic mRNA translation. Arabidopsis Book 13, e0176 ( 10.1199/tab.0176) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Karásková M, Gunišová S, Herrmannová A, Wagner S, Munzarová V, Valášek LS. 2012. Functional characterization of the role of the N-terminal domain of the c/Nip1 subunit of eukaryotic initiation factor 3 (eIF3) in AUG recognition. J. Biol. Chem. 287, 28 420–28 434. ( 10.1074/jbc.M112.386656) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Querol-Audí J, Sun C, Vogan JM, Smith MD, Gu Y, Cate JHD, Nogales E. 2013. Architecture of human translation initiation factor 3. Structure 21, 920–928. ( 10.1016/j.str.2013.04.002) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Schreier MH, Staehelin T. 1973. Initiation of eukaryotic protein synthesis: (Met-tRNAf.40S ribosome) initiation complex catalysed by purified initiation factors in the absence of mRNA. Nat. New Biol. 242, 35–38. ( 10.1038/newbio242035a0) [DOI] [PubMed] [Google Scholar]
- 29.Freienstein C, Blobel G. 1975. Nonribosomal proteins associated with eukaryotic native small ribosomal subunits. Proc. Natl Acad. Sci. USA 72, 3392–3396. ( 10.1073/pnas.72.9.3392) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sundkvist IC, Staehelin T. 1975. Structure and function of free 40S ribosome subunits: characterization of initiation factors. J. Mol. Biol. 99, 401–418. ( 10.1016/S0022-2836(75)80135-5) [DOI] [PubMed] [Google Scholar]
- 31.Benne R, Hershey JW. 1976. Purification and characterization of initiation factor IF-E3 from rabbit reticulocytes. Proc. Natl Acad. Sci. USA 73, 3005–3009. ( 10.1073/pnas.73.9.3005) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Block KL, Vornlocher HP, Hershey JW. 1998. Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3. J. Biol. Chem. 273, 31 901–31 908. ( 10.1074/jbc.273.48.31901) [DOI] [PubMed] [Google Scholar]
- 33.Damoc E, Fraser CS, Zhou M, Videler H, Mayeur GL, Hershey JWB, Doudna JA, Robinson CV, Leary JA. 2007. Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol. Cell Proteomics 6, 1135–1146. ( 10.1074/mcp.M600399-MCP200) [DOI] [PubMed] [Google Scholar]
- 34.Masutani M, Sonenberg N, Yokoyama S, Imataka H. 2007. Reconstitution reveals the functional core of mammalian eIF3. EMBO J. 26, 3373–3383. ( 10.1038/sj.emboj.7601765) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Zhou M, et al. 2008. Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc. Natl Acad. Sci. USA 105, 18 139–18 144. ( 10.1073/pnas.0801313105) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Prichard PM, Gilbert JM, Shafritz DA, Anderson WF. 1970. Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature 226, 511–514. ( 10.1038/226511a0) [DOI] [PubMed] [Google Scholar]
- 37.Heywood SM. 1970. Specificity of mRNA binding factor in eukaryotes. Proc. Natl Acad. Sci. USA 67, 1782–1788. ( 10.1073/pnas.67.4.1782) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kaempfer R, Kaufman J. 1972. Translational control of hemoglobin synthesis by an initiation factor required for recycling of ribosomes and for their binding to messenger RNA. Proc. Natl Acad. Sci. USA 69, 3317–3321. ( 10.1073/pnas.69.11.3317) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Darnbrough C, Legon S, Hunt T, Jackson RJ. 1973. Initiation of protein synthesis: evidence for messenger RNA-independent binding of methionyl-transfer RNA to the 40S ribosomal subunit. J. Mol. Biol. 76, 379–403. ( 10.1016/0022-2836(73)90511-1) [DOI] [PubMed] [Google Scholar]
- 40.Hirsch CA, Cox MA, van Venrooij WJ, Henshaw EC. 1973. The ribosome cycle in mammalian protein synthesis. II. Association of the native smaller ribosomal subunit with protein factors. J. Biol. Chem. 248, 4377–4385. [PubMed] [Google Scholar]
- 41.Ayuso-Parilla M, Henshaw EC, Hirsch CA. 1973. The ribosome cycle in mammalian protein synthesis. 3. Evidence that the nonribosomal proteins bound to the native smaller subunit are initiation factors. J. Biol. Chem. 248, 4386–4393. [PubMed] [Google Scholar]
- 42.Strycharz WA, Ranki M, Dahl HH. 1974. A high-molecular-weight protein component required for natural messenger translation in ascites tumor cells. Eur. J. Biochem. 48, 303–310. ( 10.1111/j.1432-1033.1974.tb03769.x) [DOI] [PubMed] [Google Scholar]
- 43.Trachsel H, Erni B, Schreier MH, Staehelin T. 1977. Initiation of mammalian protein synthesis. II. The assembly of the initiation complex with purified initiation factors. J. Mol. Biol. 116, 755–767. ( 10.1016/0022-2836(77)90269-8) [DOI] [PubMed] [Google Scholar]
- 44.Benne R, Hershey JW. 1978. The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. J. Biol. Chem. 253, 3078–3087. [PubMed] [Google Scholar]
- 45.Merrick WC. 1979. Purification of protein synthesis initiation factors from rabbit reticulocytes. Methods Enzymol. 60, 101–108. ( 10.1016/S0076-6879(79)60010-1) [DOI] [PubMed] [Google Scholar]
- 46.Sonenberg N, Morgan MA, Merrick WC, Shatkin AJ. 1978. A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA. Proc. Natl Acad. Sci. USA 75, 4843–4847. ( 10.1073/pnas.75.10.4843) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Sonenberg N, Rupprecht KM, Hecht SM, Shatkin AJ. 1979. Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc. Natl Acad. Sci. USA 76, 4345–4349. ( 10.1073/pnas.76.9.4345) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Tahara SM, Morgan MA, Shatkin AJ. 1981. Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells. J. Biol. Chem. 256, 7691–7694. [PubMed] [Google Scholar]
- 49.Grifo JA, Tahara SM, Morgan MA, Shatkin AJ, Merrick WC. 1983. New initiation factor activity required for globin mRNA translation. J. Biol. Chem. 258, 5804–5810. [PubMed] [Google Scholar]
- 50.Trachsel H, Staehelin T. 1979. Initiation of mammalian protein synthesis. The multiple functions of the initiation factor eIF-3. Biochim. Biophys. Acta 565, 305–314. ( 10.1016/0005-2787(79)90207-7) [DOI] [PubMed] [Google Scholar]
- 51.Peterson DT, Merrick WC, Safer B. 1979. Binding and release of radiolabeled eukaryotic initiation factors 2 and 3 during 80 S initiation complex formation. J. Biol. Chem. 254, 2509–2516. [PubMed] [Google Scholar]
- 52.Anderson WF, Bosch L, Cohn WE, Lodish H, Merrick WC, Weissbach H, Wittmann HG, Wool IG. 1977. International symposium on protein synthesis: summary of Fogarty Center-NIH workshop held in Bethesda, Maryland on 18–20 October, 1976 FEBS Lett. 76, 1–10. [DOI] [PubMed] [Google Scholar]
- 53.Pestova TV, Lomakin IB, Lee JH, Choi SK, Dever TE, Hellen CU. 2000. The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature 403, 332–335. ( 10.1038/35002118) [DOI] [PubMed] [Google Scholar]
- 54.Emanuilov I, Sabatini DD, Lake JA, Freienstein C. 1978. Localization of eukaryotic initiation factor 3 on native small ribosomal subunits. Proc. Natl Acad. Sci. USA 75, 1389–1393. ( 10.1073/pnas.75.3.1389) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lutsch G, Benndorf R, Westermann P, Behlke J, Bommer UA, Bielka H. 1985. On the structure of native small ribosomal subunits and initiation factor eIF-3 isolated from rat liver. Biomed. Biochim. Acta 44, K1–K7. [PubMed] [Google Scholar]
- 56.Behlke J, Bommer UA, Lutsch G, Henske A, Bielka H. 1986. Structure of initiation factor eIF-3 from rat liver. Hydrodynamic and electron microscopic investigations. Eur. J. Biochem. 157, 523–530. ( 10.1111/j.1432-1033.1986.tb09698.x) [DOI] [PubMed] [Google Scholar]
- 57.Srivastava S, Verschoor A, Frank J. 1992. Eukaryotic initiation factor 3 does not prevent association through physical blockage of the ribosomal subunit-subunit interface. J. Mol. Biol. 226, 301–304. ( 10.1016/0022-2836(92)90946-H) [DOI] [PubMed] [Google Scholar]
- 58.Bommer UA, Lutsch G, Stahl J, Bielka H. 1991. Eukaryotic initiation factors eIF-2 and eIF-3: interactions, structure and localization in ribosomal initiation complexes. Biochimie 73, 1007–1019. ( 10.1016/0300-9084(91)90142-N) [DOI] [PubMed] [Google Scholar]
- 59.Siridechadilok B, Fraser CS, Hall RJ, Doudna JA, Nogales E. 2005. Structural roles for human translation factor eIF3 in initiation of protein synthesis. Science 310, 1513–1515. ( 10.1126/science.1118977) [DOI] [PubMed] [Google Scholar]
- 60.Asano K, Vornlocher HP, Richter-Cook NJ, Merrick WC, Hinnebusch AG, Hershey JW. 1997. Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. Possible roles in RNA binding and macromolecular assembly. J. Biol. Chem. 272, 27 042–27 052. ( 10.1074/jbc.272.43.27042) [DOI] [PubMed] [Google Scholar]
- 61.Aravind L, Ponting CP. 1998. Homologues of 26S proteasome subunits are regulators of transcription and translation. Protein Sci. 7, 1250–1254. ( 10.1002/pro.5560070521) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Hofmann K, Bucher P. 1998. The PCI domain: a common theme in three multiprotein complexes. Trends Biochem. Sci. 23, 204–205. ( 10.1016/S0968-0004(98)01217-1) [DOI] [PubMed] [Google Scholar]
- 63.Wei N, Tsuge T, Serino G, Dohmae N, Takio K, Matsui M, Deng X-W. 1998. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol. 8, 919–922. ( 10.1016/S0960-9822(07)00372-7) [DOI] [PubMed] [Google Scholar]
- 64.Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94, 615–623. ( 10.1016/S0092-8674(00)81603-7) [DOI] [PubMed] [Google Scholar]
- 65.Scheel H, Hofmann K. 2005. Prediction of a common structural scaffold for proteasome lid, COP9-signalosome and eIF3 complexes. BMC Bioinformatics 6, 71 ( 10.1186/1471-2105-6-71) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Asano K, Phan L, Anderson J, Hinnebusch AG. 1998. Complex formation by all five homologues of mammalian translation initiation factor 3 subunits from yeast Saccharomyces cerevisiae. J. Biol. Chem. 273, 18 573–18 585. ( 10.1074/jbc.273.29.18573) [DOI] [PubMed] [Google Scholar]
- 67.Phan L, Zhang X, Asano K, Anderson J, Vornlocher HP, Greenberg JR, Qin J, Hinnebusch AG. 1998. Identification of a translation initiation factor 3 (eIF3) core complex, conserved in yeast and mammals, that interacts with eIF5. Mol. Cell Biol. 18, 4935–4946. ( 10.1128/MCB.18.8.4935) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Valásek L, Phan L, Schoenfeld LW, Valásková V, Hinnebusch AG. 2001. Related eIF3 subunits TIF32 and HCR1 interact with an RNA recognition motif in PRT1 required for eIF3 integrity and ribosome binding. EMBO J. 20, 891–904. ( 10.1093/emboj/20.4.891) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Asano K, Clayton J, Shalev A, Hinnebusch AG. 2000. A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo. Genes Dev. 14, 2534–2546. ( 10.1101/gad.831800) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Hinnebusch AG, Asano K, Olsen DS, Phan L, Nielsen KH, Valásek L. 2004. Study of translational control of eukaryotic gene expression using yeast. Ann. N.Y. Acad. Sci. 1038, 60–74. ( 10.1196/annals.1315.012) [DOI] [PubMed] [Google Scholar]
- 71.Sokabe M, Fraser CS, Hershey JWB. 2012. The human translation initiation multi-factor complex promotes methionyl-tRNAi binding to the 40S ribosomal subunit. Nucleic Acids Res. 40, 905–913. ( 10.1093/nar/gkr772) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Kolupaeva VG, Unbehaun A, Lomakin IB, Hellen CUT, Pestova TV. 2005. Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits and its role in ribosomal dissociation and anti-association. RNA 11, 470–486. ( 10.1261/rna.7215305) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Pestova TV, Hellen CU, Shatsky IN. 1996. Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. Mol. Cell Biol. 16, 6859–6869. ( 10.1128/MCB.16.12.6859) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Sizova DV, Kolupaeva VG, Pestova TV, Shatsky IN, Hellen CU. 1998. Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J. Virol. 72, 4775–4782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Fraser CS, Lee JY, Mayeur GL, Bushell M, Doudna JA, Hershey JWB. 2004. The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40S ribosomal subunits in vitro. J. Biol. Chem. 279, 8946–8956. ( 10.1074/jbc.M312745200) [DOI] [PubMed] [Google Scholar]
- 76.Smith MD, Gu Y, Querol-Audí J, Vogan JM, Nitido A, Cate JHD. 2013. Human-like eukaryotic translation initiation factor 3 from Neurospora crassa. PLoS ONE 8, e78715 ( 10.1371/journal.pone.0078715) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM. 2015. Identification and characterization of essential genes in the human genome. Science 350, 1096–1101. ( 10.1126/science.aac7041) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Blomen VA, et al. 2015. Gene essentiality and synthetic lethality in haploid human cells. Science 350, 1092–1096. ( 10.1126/science.aac7557) [DOI] [PubMed] [Google Scholar]
- 79.Andaya A, Villa N, Jia W, Fraser CS, Leary JA. 2014. Phosphorylation stoichiometries of human eukaryotic initiation factors. Int. J. Mol. Sci. 15, 11 523–11 538. ( 10.3390/ijms150711523) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Cai Q, Todorovic A, Andaya A, Gao J, Leary JA, Cate JHD. 2010. Distinct regions of human eIF3 are sufficient for binding to the HCV IRES and the 40S ribosomal subunit. J. Mol. Biol. 403, 185–196. ( 10.1016/j.jmb.2010.07.054) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Sun C, et al. 2011. Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3). Proc. Natl Acad. Sci. USA 108, 20 473–20 478. ( 10.1073/pnas.1116821108) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Fraser CS, Berry KE, Hershey JWB, Doudna JA. 2007. eIF3j is located in the decoding center of the human 40S ribosomal subunit. Mol. Cell. 26, 811–819. ( 10.1016/j.molcel.2007.05.019) [DOI] [PubMed] [Google Scholar]
- 83.Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, Martin A. 2012. Complete subunit architecture of the proteasome regulatory particle. Nature 482, 186–191. ( 10.1038/nature10774) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Lasker K, et al. 2012. Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc. Natl Acad. Sci. USA 109, 1380–1387. ( 10.1073/pnas.1120559109) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.da Fonseca PCA, He J, Morris EP. 2012. Molecular model of the human 26S proteasome. Mol. Cell 46, 54–66. ( 10.1016/j.molcel.2012.03.026) [DOI] [PubMed] [Google Scholar]
- 86.Pathare GR, et al. 2012. The proteasomal subunit Rpn6 is a molecular clamp holding the core and regulatory subcomplexes together. Proc. Natl Acad. Sci. USA 109, 149–154. ( 10.1073/pnas.1117648108) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Sun C, Querol-Audí J, Mortimer SA, Arias-Palomo E, Doudna JA, Nogales E, Cate JHD. 2013. Two RNA-binding motifs in eIF3 direct HCV IRES-dependent translation. Nucleic Acids Res. 41, 7512–7521. ( 10.1093/nar/gkt510) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Hashem Y, Georges des A, Dhote V, Langlois R, Liao HY, Grassucci RA, Hellen CUT, Pestova TV, Frank J. 2013. Structure of the mammalian ribosomal 43S preinitiation complex bound to the scanning factor DHX29. Cell 153, 1108–1119. ( 10.1016/j.cell.2013.04.036) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Hashem Y, et al. 2013. Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain access to the 40S subunit. Nature 503, 539–543. ( 10.1038/nature12658) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Erzberger JP, et al. 2014. Molecular architecture of the 40S⋅eIF1⋅eIF3 translation initiation complex. Cell 158, 1123–1135. ( 10.1016/j.cell.2014.07.044) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Aylett CHS, Boehringer D, Erzberger JP, Schaefer T, Ban N. 2015. Structure of a yeast 40S-eIF1-eIF1A-eIF3-eIF3j initiation complex. Nat. Struct. Mol. Biol. 22, 269–271. ( 10.1038/nsmb.2963) [DOI] [PubMed] [Google Scholar]
- 92.Georges des A, Dhote V, Kuhn L, Hellen CUT, Pestova TV, Frank J, Hashem Y. 2015. Structure of mammalian eIF3 in the context of the 43S preinitiation complex. Nature 525, 491–495. ( 10.1038/nature14891) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Llácer JL, Hussain T, Marler L, Aitken CE, Thakur A, Lorsch JR, Hinnebusch AG, Ramakrishnan V. 2015. Conformational differences between open and closed states of the eukaryotic translation initiation complex. Mol. Cell 59, 399–412. ( 10.1016/j.molcel.2015.06.033) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Simonetti A, Brito Querido J, Myasnikov AG, Mancera-Martinez E, Renaud A, Kuhn L, Hashem Y. 2016. eIF3 peripheral subunits rearrangement after mRNA binding and start-codon recognition. Mol. Cell 63, 206–217. ( 10.1016/j.molcel.2016.05.033) [DOI] [PubMed] [Google Scholar]
- 95.Hafner M, et al. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141. ( 10.1016/j.cell.2010.03.009) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Pisarev AV, Kolupaeva VG, Yusupov MM, Hellen CUT, Pestova TV. 2008. Ribosomal position and contacts of mRNA in eukaryotic translation initiation complexes. EMBO J. 27, 1609–1621. ( 10.1038/emboj.2008.90) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Lee ASY, Kranzusch PJ, Cate JHD. 2015. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature 522, 111–114. ( 10.1038/nature14267) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Bhat M, Robichaud N, Hulea L, Sonenberg N, Pelletier J, Topisirovic I. 2015. Targeting the translation machinery in cancer. Nat. Rev. Drug Discov. 14, 261–278. ( 10.1038/nrd4505) [DOI] [PubMed] [Google Scholar]
- 99.Hsieh AC, et al. 2012. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55–61. ( 10.1038/nature10912) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109–113. ( 10.1038/nature11083) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Blau L, Knirsh R, Ben-Dror I, Oren S, Kuphal S, Hau P, Proescholdt M, Bosserhoff A-K, Vardimon L. 2012. Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc. Natl Acad. Sci. USA 109, E2875–E2884. ( 10.1073/pnas.1203659109) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Lee ASY, Kranzusch PJ, Doudna JA, Cate JH. 2016. eIF3d is an mRNA cap-binding protein required for specialized translation initiation. Nature 536, 96–99. ( 10.1038/nature18954) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Sonenberg N, Morgan MA, Testa D, Colonno RJ, Shatkin AJ. 1979. Interaction of a limited set of proteins with different mRNAs and protection of 5'-caps against pyrophosphatase digestion in initiation complexes. Nucleic Acids Res. 7, 15–29. ( 10.1093/nar/7.1.15) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Chang JH, Jiao X, Chiba K, Oh C, Martin CE, Kiledjian M, Tong L. 2012. Dxo1 is a new type of eukaryotic enzyme with both decapping and 5′-3″ exoribonuclease activity. Nat. Struct. Mol. Biol. 19, 1011–1017. ( 10.1038/nsmb.2381) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Carlsten JOP, Zhu X, Gustafsson CM. 2013. The multitalented mediator complex. Trends Biochem. Sci. 38, 531–537. ( 10.1016/j.tibs.2013.08.007) [DOI] [PubMed] [Google Scholar]
- 106.Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, Pestova TV, Qian S-B, Jaffrey SR. 2015. 5' UTR m(6)A promotes cap-independent translation. Cell 163, 999–1010. ( 10.1016/j.cell.2015.10.012) [DOI] [PMC free article] [PubMed] [Google Scholar]